In short
Novartis AG (NOVN.SW) has revenue up 9.6% to $56.7B and net income up 17.1% to $14.0B year on year. Its net margin is 24.7% and gross margin 75.8%, and it trades at 22.4× trailing earnings. Fisclear flags 1 medium-severity risk and no high-severity ones. How we calculate this
Valuation
HealthcareLive · Yahoo FinancePrice
CHF 119.10
CHF 226.4B
11.6x
3.11%
52-Week Range
4-engine score — Quality and Peers engines require SEC EDGAR (US stocks only)
ROE 30.3% — exceptional capital return.
Operating margin 31.1% — high profitability.
FCF yield 6.7% — strong cash generation.
Based on filing period ending Dec 2025
International FisclearScore uses 4 engines (no EDGAR data). Based on Yahoo Finance & Alpha Vantage reported financials. Not financial advice.
🇨🇭 Switzerland Macro Indicators
Full dashboard →10-Year Yield
0.47%→
USD/CHF
0.83→
The 10-year government bond yield is 0.47%; USD/CHF is at 0.8293.
SWOT Analysis — NOVN.SW
Inflationary BoomStrengths
EPS (Diluted): USD 7.15 (+21.8% YoY) — Earnings per share rose 22% — each share earned more.
Net Income: $14.0B (+17.1% YoY) — Profit grew 17% — the company kept more of each dollar earned.
Gross Profit: $43.0B (+10.5% YoY) — Gross profit rose 10% — the spread between revenue and direct costs improved.
Revenue: $56.7B (+9.6% YoY) — Revenue grew 10% — the company sold more goods or services than the prior year.
Operating Cash Flow: $19.1B (+8.7% YoY) — Operating cash flow grew 9% — the business generated more cash from day-to-day operations.
Weaknesses
No material weaknesses flagged.
Opportunities
No clear opportunities identified at this time.
Threats
Current ratio of 1.12x — thin liquidity buffer against short-term obligations.
Financial Charts
Year-over-Year Changes
EPS (Diluted)
USD 7.15
was USD 5.87
Earnings per share rose 22% — each share earned more.
Net Income
$14.0B
was $11.9B
Profit grew 17% — the company kept more of each dollar earned.
Gross Profit
$43.0B
was $38.9B
Gross profit rose 10% — the spread between revenue and direct costs improved.
Revenue
$56.7B
was $51.7B
Revenue grew 10% — the company sold more goods or services than the prior year.
Operating Cash Flow
$19.1B
was $17.6B
Operating cash flow grew 9% — the business generated more cash from day-to-day operations.
Risk Flags
0 high · 1 medium · 0 low- ◈ Medium
Current ratio of 1.12x — thin liquidity buffer against short-term obligations.
Price HistoryCHF
Technical Signals
Daily closes · 1-year dataLatest News
via FinnhubGet the weekly digest
5 company reports + macro context every week, free. No spam.
- Unlimited goal simulations
- 5 free company report summaries per day
- Weekly financial insights newsletter
External Links
Research Novartis AG
Data sourced from SIX, FRED (Federal Reserve), OECD, BIS, and Yahoo Finance. For informational purposes only. Not financial advice.